Research programme: anti-infectives - Lallemand Aquapharm
Alternative Names: AQP 182Latest Information Update: 13 Oct 2021
At a glance
- Originator Aquapharm Biodiscovery
- Developer Aquapharm Biodiscovery; Lallemand Aquapharm
- Class Peptides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Bacterial infections; Gram-negative infections; Gram-positive infections; Mycoses
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Gram-negative-infections in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Gram-positive-infections in United Kingdom